Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy

Archives of Neurology

Volumn 66, Issue 4, 2009, Pages 458-464

  Niehusmann, Pitt ^a   Dalmau, Josep ^b   Rudlowski, Christian ^a   Vincent, Angela ^c   Elger, Christian E ^a   Rossi, Jeffrey E ^b   Bien, Christian G ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; VOLTAGE GATED POTASSIUM CHANNEL;

ADOLESCENT; ADULT; ARTICLE; BRAIN DYSFUNCTION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; EPILEPSY; FEMALE; HUMAN; MENTAL DISEASE; NEUROENDOCRINE TUMOR; PLEOCYTOSIS; PRIORITY JOURNAL; SEIZURE; TREATMENT RESPONSE; AGE; AGED; ANIMAL; CASE CONTROL STUDY; DIFFERENTIAL DIAGNOSIS; HIPPOCAMPUS; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; NEUROPIL; PARANEOPLASTIC SYNDROME; PATHOLOGY; RAT; REFERENCE VALUE; WISTAR RAT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANIMALS; AUTOANTIBODIES; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; EPILEPSY; FEMALE; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEUROPIL; PARANEOPLASTIC SYNDROMES; POTASSIUM CHANNELS, VOLTAGE-GATED; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; REFERENCE VALUES;

EID: 65249132928     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.5     Document Type: Article

References (27)

1. Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61 (1):25-36.
2. Sansing LH, Tüzün E, Ko MW, Baccon J, Lynch DR, Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol. 2007;3(5):291-296.
3. lizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long- term outcome without tumor removal. Neurology. 2008;70(7):504-511.
4. Novillo-Lopez ME, Rossi JE, Dalmau J, Masjuan J. Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology. 2008;70(9):728-729.
5. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75 (8):1135-1140.
6. Tizin E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007;13(5):261-271.
7. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis. Lancet Neurol. 2008;7(12):1091-1108.
8. Reiber H. The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph forthe protein profile of cerebrospinal fluid. J Neurol. 1980;224(2):89-99.
9. Ances BM, Vitaliani R, Taylor RA, etal. Treatment-responsive limbic encephalitis identified by neuropil antibodies. Brain. 2005;128(pt 8):1764-1777.
10. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy. Brain. 2004;127(pt3):701-712.
11. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7(4):327-340.
12. Solimena M, Folli F, Denis Donini S, et al. Autoantibodies to glutamic acid de- carboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med. 1988;318(16):1012-1020.
13. Saiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008;131(pt 10):2553-2563.
14. Hart IK, Waters C, Vincent A, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol. 1997;41(2):238-246.
15. McKnight K, Jiang Y, Hart Y, et al. Serum antibodies in epilepsy and seizure- associated disorders. Neurology. 2005;65(11):1730-1736.
16. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989;30(4):389-399.
17. Castillo P, Woodruff B, Caselli R, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006;63(2):197-202.
18. Bauer J, Elger CE, Hans VH, et al. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol. 2007;62(1):67-80.
19. Furlong MA, Fanburg-Smith JC, Miettinen M. The morphologic spectrum of hibernoma. Am J Surg Pathol. 2001;25(6):809-814.
20. Bien CG, Urbach H, Schramm J, et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology. 2007;69(12):1236-1244.
21. Mula M, Trimble MR, Thompson P, Sander JW. Topiramate and word-finding difficulties in patients with epilepsy. Neurology. 2003;60(7):1104-1107.
22. Mocellin R, Walterfang M, Velakoulis D. Hashimoto's encephalopathy: epidemiology, pathogenesis and management. CNS Drugs. 2007;21(10):799-811.
23. Stone JM, Morrison PD, Pilowsky LS. Glutamate and dopamine dysregulation in schizophrenia. J Psychopharmacol. 2007;21(4):440-452.
24. Vincent A, McConville J, Farrugia ME, et al. Antibodies in myasthenia gravis and related disorders. Ann N Y Acad Sci. 2003;998:324-335.
25. Buckley C, Vincent A. Autoimmune channelopathies. Nat Clin Pract Neurol. 2005; 1(1):22-33.
26. Bataller L, Kleopa KA, Wu GF, Rossi JE, Rosenfeld MR, Dalmau J. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry. 2007;78(4):381-385.
27. Graus F, Saiz A, Lai M, et al. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology. 2008;71(12):930-936.